Eventide Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,475,054	Closed	-$13.6M	–	257
2024 Q4	$13.6M	Sell	4,475,054 -4,072,842	-48%	-$13.3M	0.25%	118
2024 Q3	$31.5M	Hold	8,547,896	–	–	0.54%	64
2024 Q2	$35M	Sell	8,547,896 -3,026,925	-26%	-$33.8M	0.6%	56
2024 Q1	$182M	Buy	11,574,821 +14,846	+0.1%	+$204K	2.86%	2
2023 Q4	$175M	Buy	11,559,975 +3,745,936	+48%	+$54.7M	2.86%	3
2023 Q3	$157M	Buy	7,814,039 +936,236	+14%	+$23.8M	2.82%	4
2023 Q2	$194M	Buy	6,877,803 +3,650,803	+113%	+$87.6M	3.28%	1
2023 Q1	$55.5M	Buy	3,227,000 +1,070,485	+50%	+$21.7M	1.02%	32
2022 Q4	$43.4M	Buy	2,156,515 +295,515	+16%	+$6.36M	0.86%	41
2022 Q3	$40.3M	Buy	1,861,000 +857,000	+85%	+$23.4M	0.79%	49
2022 Q2	$28.2M	Buy	1,004,000 +243,000	+32%	+$6.44M	0.6%	58
2022 Q1	$35.1M	Buy	761,000 +232,000	+44%	+$12.5M	0.55%	60
2021 Q4	$44.5M	Hold	529,000	–	–	0.57%	60
2021 Q3	$35.3M	Buy	529,000 +108,600	+26%	+$6.26M	0.47%	71
2021 Q2	$22.4M	Sell	420,400 -411,600	-49%	-$22M	0.3%	89
2021 Q1	$36.1M	Hold	832,000	–	–	0.54%	69
2020 Q4	$43.2M	Sell	832,000 -79,416	-9%	-$3.58M	0.67%	55
2020 Q3	$28.8M	Sell	911,416 -3,289	-0.4%	-$115K	0.58%	60
2020 Q2	$42.5M	Buy	+914,705	New	+$35.1M	0.95%	39

Other funds holding ZNTL